MYDA Advisors’s Insmed INSM Stock Holding History

MYDA Advisors’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.6M	Buy	+15,000	New	+$1.82M	0.24%	89
2025 Q3	–	Sell	-25,000	Closed	-$2.52M	–	188
2025 Q2	$2.52M	Buy	+25,000	New	+$1.91M	0.44%	61

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

MYDA Advisors's INSM Position: Q2 2026 in Review

MYDA Advisors held its Insmed (INSM) position steady in Q2 2026 at 7,000 shares worth $746K. The position accounts for 0.11% of the portfolio, ranked #127.

MYDA Advisors first reported a position in INSM in Q3 2024 and has held it in 7 quarters since. The position peaked at $3.22M in Q2 2025. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

MYDA Advisors held 7,000 shares of Insmed worth $746K as of Q2 2026.
MYDA Advisors left its Insmed share count unchanged in Q2 2026.
Insmed made up 0.11% of MYDA Advisors's portfolio in Q2 2026, its #127 holding.
MYDA Advisors first reported a position in Insmed in Q3 2024 and has held it in 7 quarters since.
MYDA Advisors's Insmed position peaked at $3.22M in Q2 2025.
666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on MYDA Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.